Target intelligence / Profile preview

Long intergenic non-protein coding RNA 351 (LINC00351)

Target
LINC00351
Molecular classification
Other (non-coding RNA, specifically long intergenic non-coding RNA)
01

Overview

LINC00351, or long intergenic non-protein coding RNA 351, is a human gene that generates a non-coding RNA transcript over 200 nucleotides in length. This type of RNA is not translated into a protein but instead plays diverse roles in regulating gene expression, chromatin remodeling, and maintaining genomic architecture. LINC00351 belongs to the class of long intergenic non-coding RNAs (lincRNAs), which often function in a tissue-specific manner to fine-tune neighboring gene activity through multiple mechanisms. Although lincRNAs as a group have been implicated in various cellular and disease processes, no validated, direct functional or disease-specific associations are currently reported for LINC00351[1][5][7][9][13][15]. There is no evidence that LINC00351 acts as a conventional therapeutic target (such as a receptor, enzyme, transporter, or transcription factor). It is also not commonly associated with biomarkers, specific drugs, or direct safety concerns; its classification is strictly as a long intergenic non-coding RNA, primarily involved in regulation at the RNA level.

Other names
LINC00351long intergenic non-protein coding RNA 351
02

Biological functions

Chromatin remodelingRegulation of genome architectureRNA stabilizationRegulation of transcriptionFine-tuning expression of neighboring genes
03

Disease associations

Other (Potential regulatory roles in various disease processes through gene expression modulation; no direct, validated roles in cancer, inflammation, or specific diseases yet established)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 351 (LINC00351).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 351 (LINC00351).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call